Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia

Experimental Hematology

Volumn 33, Issue 3, 2005, Pages 344-352

  Romanski, Annette ^a   Bug, Gesine ^a   Becker, Sven ^b   Kampfmann, Manuela ^a   Seifried, Erhard ^b   Hoelzer, Dieter ^a   Ottmann, Oliver G ^a   Tonn, Torsten ^b  

^a GOETHE UNIVERSITY   (Germany)

^b Inst Transfus Med I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; PRIORITY JOURNAL;

MICA;

EID: 13844314521     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.11.006     Document Type: Article

References (35)

1. J.V. Teichmann, W.D. Ludwig, and E. Thiel Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor Leuk Res 16 1992 287 298
2. G. Pawelec MHC-unrestricted immune surveillance of leukemia Cancer Biother 9 1994 265 288
3. M.C. Dokhelar, J. Wiels, and M. Lipinski Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease Transplantation 31 1981 61 65
4. G. Maki, G. Krystal, and G. Dougherty Induction of sensitivity to NK-mediated cytotoxicity by TNF-alpha treatment: possible role of ICAM-3 and CD44 Leukemia 12 1998 1565 1572
5. M.J. Smyth, Y. Hayakawa, and K. Takeda New aspects of natural-killer-cell surveillance and therapy of cancer Nat Rev Cancer 2 2002 850 861
6. S. Rajagopalan, and E.O. Long A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells J Exp Med 189 1999 1093 1100
7. M. Ponte, C. Cantoni, and R. Biassoni Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor Proc Natl Acad Sci U S A 96 1999 5674 5679
8. L.L. Lanier Natural killer cells fertile with receptors for HLA-G? Proc Natl Acad Sci U S A 96 1999 5343 5345
9. G. Chumbley, A. King, and K. Robertson Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells Cell Immunol 155 1994 312 322
10. L. Pazmany, O. Mandelboim, and M. Vales-Gomez Protection from natural killer cell-mediated lysis by HLA-G expression on target cells Science 274 1996 792 795
11. O. Mandelboim, L. Pazmany, and D.M. Davis Multiple receptors for HLA-G on human natural killer cells Proc Natl Acad Sci U S A 94 1997 14666 14670
12. F. Navarro, M. Llano, and T. Bellon The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells Eur J Immunol 29 1999 277 283
13. L. Ruggeri, M. Capanni, and E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
14. J.A. Trapani, J. Davis, and V.R. Sutton Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo Curr Opin Immunol 12 2000 323 329
15. D. Kagi, B. Ledermann, and K. Burki Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice Nature 369 1994 31 37
16. C. Lehmann, M. Zeis, and N. Schmitz Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells Blood 96 2000 594 600
17. C. Lehmann, M. Zeis, and L. Uharek Activation of natural killer cells with interleukin 2 (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells Br J Haematol 114 2001 660 665
18. Y. Yan, P. Steinherz, and H.G. Klingemann Antileukemia activity of a natural killer cell line against human leukemias Clin Cancer Res 4 1998 2859 2868
19. J.H. Gong, G. Maki, and H.G. Klingemann Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells Leukemia 8 1994 652 658
20. S. Maier, D.E. Geraghty, and E.H. Weiss Expression and regulation of HLA-G in human glioma cell lines Transplant Proc 31 1999 1849 1853
21. S. Tohda, C. Sakashita, and T. Fukuda Establishment of a double Philadelphia chromosome-positive acute lymphoblastic leukemia-derived cell line, TMD5: effects of cytokines and differentiation inducers on growth of the cells Leuk Res 23 1999 255 261
22. H.G. Klingemann, E. Wong, and G. Maki A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood Biol Blood Marrow Transplant 2 1996 68 75
23. A.C. Budinsky, T. Brodowicz, and C. Wiltschke Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro Int J Cancer 71 1997 1086 1090
24. H.R. Salih, H. Antropius, and F. Gieseke Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia Blood 102 2003 1389 1396 Epub 2003 Apr 24
25. Y. Oshimi, S. Oda, and Y. Honda Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells J Immunol 157 1996 2909 2915
26. S. Mori, A. Jewett, and K. Murakami-Mori The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent Cancer Immunol Immunother 44 1997 282 290
27. G. Bossi, and G.M. Griffiths Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells Nat Med 5 1999 90 96
28. N. Seki, A.D. Brooks, and C.R. Carter Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin J Immunol 168 2002 3484 3492
29. L. Ruggeri, M. Capanni, and M. Casucci Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 94 1999 333 339
30. F. Aoudjit, E.F. Potworowski, and Y. St-Pierre Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1 J Immunol 160 1998 2967 2973
31. E. Fiore, C. Fusco, and P. Romero Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity Oncogene 21 2002 5213 5223
32. K. Polakova, M. Krcova, and D. Kuba Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients Leuk Res 27 2003 643 648
33. G. Maki, H.G. Klingemann, and J.A. Martinson Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92 J Hematother Stem Cell Res 10 2001 369 383
34. R.T. Costello, S. Sivori, and E. Marcenaro Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia Blood 99 2002 3661 3667
35. C. Uherek, T. Tonn, and B. Uherek Retargeting of natural killercell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction Blood 100 2002 1265 1273